Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company that develops, manufactures, and sells prescription medicines, primarily focused on treating serious diseases like cancer.

Why it’s in the news: It is in the news due to ongoing merger talks with AstraZeneca and its recent partnerships in AI with Anthropic and NVIDIA.

Latest on Bristol Myers Squibb

• An AstraZeneca, Bristol Myers Squibb merger could create a cancer-drug giant, but analysts call it ‘odd’
• AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up
• STAT+: Bristol Myers Squibb becomes latest company to claim it’s building pharma’s largest NVIDIA AI supercomputer
• Anthropic signs enterprise AI deal with Bristol Myers Squibb
• Wikidata: Bristol-Myers Squibb — located in — United States
• Wikidata: Bristol-Myers Squibb — operates in — pharmaceutical industry
• Wikidata: Bristol-Myers Squibb — capital ownership — Kosan Biosciences
• Wikidata: Bristol-Myers Squibb — capital ownership — Bristol-Myers Squibb (Japan)
• Wikidata: Bristol-Myers Squibb — capital ownership — Bristol Myers Squibb (Canada)
• Wikidata: Bristol-Myers Squibb — capital ownership — Bristol-Myers Squibb (India)
• Wikidata: Bristol-Myers Squibb — capital ownership — Bristol-Myers Squibb (Germany)
• Wikidata: Bristol-Myers Squibb — led by — Giovanni Caforio

Connections

15 entities linked to Bristol Myers Squibb across the news graph.